{"id":"ats907","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ATS907 acts as a selective S1P1 receptor antagonist, which has been shown to have anti-inflammatory effects. This mechanism of action is being explored for the treatment of various autoimmune diseases.","oneSentence":"ATS907 is a small molecule that targets the S1P1 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:29:33.941Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe atopic dermatitis"}]},"trialDetails":[{"nctId":"NCT01520116","phase":"PHASE1, PHASE2","title":"Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension","status":"UNKNOWN","sponsor":"Altheos, Inc.","startDate":"2012-01","conditions":"Primary Open Angle Glaucoma, Ocular Hypertension","enrollment":180},{"nctId":"NCT01668524","phase":"PHASE2","title":"ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects","status":"COMPLETED","sponsor":"Altheos, Inc.","startDate":"2012-08","conditions":"Primary Open Angle Glaucoma, Ocular Hypertension","enrollment":12}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"ATS907","genericName":"ATS907","companyName":"Altheos, Inc.","companyId":"altheos-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ATS907 is a small molecule that targets the S1P1 receptor. Used for Moderate to severe atopic dermatitis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}